Quinolinone derivatives
Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
09.12.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided. |
---|---|
AbstractList | Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided. |
Author | TAYLOR Clarke PECCHI Sabina MACHAJEWSKI Timothy D McBRIDE Christopher RENHOWE Paul A McCREA William R JAZAN Elisa HEISE Carla SHAFER Cynthia M |
Author_xml | – fullname: PECCHI Sabina – fullname: MACHAJEWSKI Timothy D – fullname: McCREA William R – fullname: RENHOWE Paul A – fullname: McBRIDE Christopher – fullname: SHAFER Cynthia M – fullname: TAYLOR Clarke – fullname: JAZAN Elisa – fullname: HEISE Carla |
BookMark | eNrjYmDJy89L5WQQDyzNzMvPyQTxFFJSizLLEksyy1KLeRhY0xJzilN5oTQ3g4yba4izh25qQX58anFBYnJqXmpJvGOAkYG5gaMxAWkAb5Uh-w |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AP2070A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AP2070A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:13:06 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AP2070A3 |
Notes | Application Number: AP20040003166 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091209&DB=EPODOC&CC=AP&NR=2070A |
ParticipantIDs | epo_espacenet_AP2070A |
PublicationCentury | 2000 |
PublicationDate | 20091209 |
PublicationDateYYYYMMDD | 2009-12-09 |
PublicationDate_xml | – month: 12 year: 2009 text: 20091209 day: 09 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
RelatedCompanies | NOVARTIS VACCINES AND DIAGNOSTICS, INC |
RelatedCompanies_xml | – name: NOVARTIS VACCINES AND DIAGNOSTICS, INC |
Score | 2.7528136 |
Snippet | Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Quinolinone derivatives |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091209&DB=EPODOC&locale=&CC=AP&NR=2070A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTRMNgb2Mgx1LSyNzHRNjExSdJOSUy11gVVRShKwbDBLTgOv8vUz8wg18YowjWBiSIXthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5qsN6xJWgrqJqLk61rgL-Lv7Oas7OtY4CaXxBQztzAkZmBFdiCNgdlBNcwJ9CGlALk2sRNkIEtAGhQXokQA1NqnjADpzPs0jVhBg5f6Fw3kAnNdsUiDOKBpZl5oNt18vNSFVKAaaYMfFx3sSiDjJtriLOHLtCGeLhP4h0DwO4wFmNgAemQYFAwSDUxNko2sTRLtQQFmUGScVqShQmwyjCwNDJPS0qWZBDFaoQUDnFpBi4j6A0HBpYyDCwlRaWpssBqsyRJDuxpAOKtclw |
link.rule.ids | 230,309,783,888,25576,76882 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTRMNgb2Mgx1LSyNzHRNjExSdJOSUy11gVVRShKwbDBLTgOv8vUz8wg18YowjWBiSIXthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5qsN6xJWgrqJqLk61rgL-Lv7Oas7OtY4CaXxBQztzAkZmBFdi6tgBddOAa5gTakFKAXJu4CTKwBQANyisRYmBKzRNm4HSGXbomzMDhC53rBjKh2a5YhEE8sDQzD3S7Tn5eqkIKMM2UgY_rLhZlkHFzDXH20AXaEA_3SbxjANgdxmIMLCAdEgwKBqkmxkbJJpZmqZagIDNIMk5LsjABVhkGlkbmaUnJkgyiWI2QwiEuz8DpEeLrE-_j6ectzcBlBL3twMBShoGlpKg0VRZYhZYkyYEDAABmF3VM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Quinolinone+derivatives&rft.inventor=PECCHI+Sabina&rft.inventor=MACHAJEWSKI+Timothy+D&rft.inventor=McCREA+William+R&rft.inventor=RENHOWE+Paul+A&rft.inventor=McBRIDE+Christopher&rft.inventor=SHAFER+Cynthia+M&rft.inventor=TAYLOR+Clarke&rft.inventor=JAZAN+Elisa&rft.inventor=HEISE+Carla&rft.date=2009-12-09&rft.externalDBID=A&rft.externalDocID=AP2070A |